Exiqon's Q3 Revenues Climb 11 Percent
October 30, 2012
Exiqon's Q3 Revenues Climb 11 Percent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Exiqon's Q1 Revenues Decline 13 Percent
May 8, 2012 / GenomeWeb Daily News - Exiqon's Q3 Revenues Increase 30 Percent
November 10, 2011 / GenomeWeb Daily News - Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News - Cancer Genetics Reports 45 Percent Increase in Q1 Revenues, Maps out Growth Strategy
May 16, 2013 / GenomeWeb Daily News - RXi Q1 Loss Rises on Opko Deal Charge
May 16, 2013 / Gene Silencing News